Aegis Surgery: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Aegis Surgery
Largest movements
- Receivables within one year +€25,010
up €25,010 (+123%), from €20,357 to €45,367
of which Other amounts receivable: +€23,321
- Deferred charges and accrued income -€2,208
down €2,208 (-21.5%), from €10,250 to €8,042
- Tangible fixed assets -€2,127
down €2,127 (-50.2%), from €4,241 to €2,114
- Cash -€922
down €922 (-8.4%), from €11,016 to €10,094
mainly Receivables within one year (-€25,010) and Trade debts (-€147)
- Profit (loss) carried forward +€19,939
up €19,939 (+56.8%), from €35,085 to €55,024
- Gross operating margin -€18,298
down €18,298 (-39.9%), from €45,827 to €27,528
- Taxes -€3,667
down €3,667 (-36.7%), from €10,000 to €6,333
- Depreciation +€1,184
up €1,184 (+126%), from €943 to €2,127
- Financial income +€794
up €794 (+253%), from €314 to €1,107
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €45,864 | €65,617 | +€19,753 | +43.1% |
| Fixed assets | 21/28 | €4,241 | €2,114 | -€2,127 | -50.2% |
| Tangible fixed assets | 22/27 | €4,241 | €2,114 | -€2,127 | -50.2% |
| Furniture and vehicles | 24 | €4,241 | €2,114 | -€2,127 | -50.2% |
| Current assets | 29/58 | €41,623 | €63,503 | +€21,880 | +52.6% |
| Amounts receivable within one year | 40/41 | €20,357 | €45,367 | +€25,010 | +123% |
| Trade receivables | 40 | €10,311 | €12,000 | +€1,689 | +16.4% |
| Other amounts receivable | 41 | €10,046 | €33,367 | +€23,321 | +232% |
| Cash at bank and in hand | 54/58 | €11,016 | €10,094 | -€922 | -8.4% |
| Deferred charges and accrued income | 490/1 | €10,250 | €8,042 | -€2,208 | -21.5% |
| Total equity and liabilities | 10/49 | €45,864 | €65,617 | +€19,753 | +43.1% |
| Equity | 10/15 | €35,185 | €55,124 | +€19,939 | +56.7% |
| Contributions | 10/11 | €100 | €100 | = | 0.0% |
| Profit (loss) carried forward | 14 | €35,085 | €55,024 | +€19,939 | +56.8% |
| Amounts payable | 17/49 | €10,679 | €10,493 | -€186 | -1.7% |
| Amounts payable within one year | 42/48 | €10,679 | €10,493 | -€186 | -1.7% |
| Trade debts | 44 | €156 | €9 | -€147 | -94.1% |
| Suppliers | 440/4 | €156 | €9 | -€147 | -94.1% |
| Taxes, remuneration and social security | 45 | €10,523 | €10,483 | -€40 | -0.4% |
| Taxes | 450/3 | €10,523 | €10,483 | -€40 | -0.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €943 | €2,127 | +€1,184 | +126% |
| Other operating charges | 640/8 | €73 | €205 | +€131 | +179% |
| Gross operating margin | 9900 | €45,827 | €27,528 | -€18,298 | -39.9% |
| Operating profit (loss) | 9901 | €44,810 | €25,196 | -€19,613 | -43.8% |
| Financial income | 75/76B | €314 | €1,107 | +€794 | +253% |
| Recurring financial income | 75 | €314 | €1,107 | +€794 | +253% |
| Financial charges | 65/66B | €39 | €32 | -€7 | -17.7% |
| Recurring financial charges | 65 | €39 | €32 | -€7 | -17.7% |
| Profit (loss) for the period before taxes | 9903 | €45,085 | €26,272 | -€18,813 | -41.7% |
| Income taxes | 67/77 | €10,000 | €6,333 | -€3,667 | -36.7% |
| Profit (loss) for the period | 9904 | €35,085 | €19,939 | -€15,146 | -43.2% |
| Profit (loss) for the period to be appropriated | 9905 | €35,085 | €19,939 | -€15,146 | -43.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.